Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's

News   May 09, 2013

 
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's
 
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE